Diaverum
is the second largest corporate dialysis clinic operator in Europe with ancillary businesses in South America and Australia. Headquartered in Sweden, it has 170 clinics in 14 countries serving over 14,000 patients.Investment overview
| Sector | Localización | Adquisición | Tamaño de la operación |
|---|---|---|---|
| Healthcare | Sweden | 2007 | N/D |
Originally part of a larger quoted medical technology group, Diaverum was identified as a non-core asset when Bridgepoint acquired the business. The company treats patients suffering from end stage renal disease who must undergo dialysis (on average 150 treatments a year) to eliminate toxins and fluids arising from failing kidney function. To learn more about the company, visit www.diaverum.com